H. Herlitz et al., RELATIONSHIP BETWEEN SODIUM-LITHIUM COUNTERTRANSPORT AND INSULIN SENSITIVITY IN MILD HYPERTENSION, Journal of internal medicine, 239(3), 1996, pp. 235-240
Objectives. To study the relationship between insulin sensitivity and
sodium-lithium countertransport (Na+-Li+ CT) in mild, essential hypert
ension, and to investigate the effect of metformin and metoprolol, res
pectively. Design. A double-blind, triple cross-over, placebo-controll
ed study over a total period of 18 weeks. Setting. A hypertension out-
patient clinic and research laboratory at Sahlgrenska University Hospi
tal. Subjects, Seventeen non-obese men with mild essential hypertensio
n and 17 weight-matched, healthy controls. Interventions. Metformin 85
0 mg b.i.d., metoprolol CR 100 mg once daily and placebo were given du
ring 18 weeks. Each treatment period was 6 weeks. A euglycaemic clamp
was performed and erythrocyte Na+-Li+ CT measured after each 6-week tr
eatment period. Main outcome measures. Insulin sensitivity, erythrocyt
e Na+-Li+ CT, their interrelation, and the effect of metformin and met
oprolol CR on both variables, respectively. Results. The hypertensive
men tended to have an elevated Na+-Li+ CT compared with the control su
bjects (0.34 +/- 0.03 versus 0.26 +/- 0.02 mmol L(-1) h(-1), P < 0.1).
Glucose disposal rate was similar, but plasma insulin levels higher (
P < 0.05) among the hypertensives than the controls. Na+-Li+ CT exhibi
ted a positive relationship to BMI (r = 0.53, P = 0.03) and a negative
correlation to glucose disposal rate (r = -0.66, P = 0.008) in the hy
pertensive subjects. In multiple regression analysis, Na+-Li+ CT showe
d a significant correlation to glucose disposal rate only. In the cont
rol subjects, there was no relation between glucose metabolism and Na-Li+ CT. Neither metformin nor metoprolol influenced Na+-Li+ CT, gluco
se disposal rate or plasma insulin. Conclusion. Erythrocyte Na+-Li+ CT
seemed to be closely related to insulin-glucose metabolism in mild hy
pertension, but was not influenced by metformin or metoprolol.